List of works - Raymond P Goodrich

<scp>SARS‐CoV</scp>‐2 seroprevalence among blood donors in Uganda: 2019–2022

scientific article published in 2023

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

scientific article published on 20 March 2009

A novel cancer immunotherapy utilizing autologous tumour tissue

scientific article published on 06 May 2020

A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia

scientific article

An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage

scientific article

Characterization of posttransfusion Plasmodium falciparum infection in semi-immune nonparasitemic patients

scientific article published on 24 June 2016

Chemical and biological mechanisms of pathogen reduction technologies

scientific article

Comparison of computerized formulae for determination of platelet recovery and survival

scientific article published on 01 July 2005

Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects

scientific article published on 01 May 2006

Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light.

scientific article

Development of a riboflavin and ultraviolet light‐based device to treat whole blood ⬇️

scientific article published on January 1, 2013

Dramatic improvements in viral inactivation with brominated psoralens, naphthalenes and anthracenes

scientific article published on 01 July 1993

Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial

scientific article

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

scientific article

Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates.

scientific article published on 5 April 2017

Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies

scientific article published in 2023

Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood ⬇️

scientific article published on August 9, 2011

Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis.

scientific article

Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

scientific article published in June 2005

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.

scientific article

FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety ⬇️

scientific article published on March 10, 2011

Functional inactivation of white blood cells by Mirasol treatment.

scientific article

Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions.

scientific article published on 13 December 2010

Hemostatic efficacy of pathogen-inactivated- versus untreated- platelets: a randomized controlled trial.

scientific article

Ignorance is not bliss.

scientific article

Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice

scientific article

Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function

scientific article published on 26 October 2010

Improving blood safety and patient outcomes with pathogen reduction technology

scientific article published on 09 November 2011

Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.

scientific article

In reply to: "Is the SCID mouse model applicable to human acute lung injury?".

scientific article

In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology

scientific article published on 4 October 2010

In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days

scientific article published on 20 October 2011

In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood.

scientific article published on 28 January 2011

Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light

scientific article published on 16 January 2013

Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates

scientific article published on 18 August 2009

Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.

scientific article published on 13 January 2015

Measurement of transmitted light as an indicator of cryopreserved platelet viability

scientific article published on 01 March 1996

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

scientific article

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

scientific article published on 31 January 2011

Pathogen Reduction of SARS-CoV-2 Virus in Plasma and Whole Blood using Riboflavin and UV Light

scientific article published on 05 May 2020

Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.

scientific article published in February 2006

Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.

scientific article

Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light

scientific article published on 29 May 2020

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

scientific article published in August 2004

Pathogen reduction of whole blood: utility and feasibility.

scientific article published on 5 September 2017

Photochemical and photophysical studies of 3-amino-6-iodoacridine and the inactivation of lambda phage

scientific article published on 01 October 1996

Photochemical eradication of methicillin-resistant Staphylococcus aureus by blue light activation of riboflavin.

scientific article

Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system

scientific article published on 25 May 2012

Pilot Acute Safety Evaluation of Innocell™ Cancer Immunotherapy in Canine Subjects

scientific article published on 08 October 2020

Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.

scientific article published on 29 June 2013

Preparation of cryoprecipitate from riboflavin and UV light-treated plasma ⬇️

scientific article published on February 17, 2012

Preservation of metabolic activity in lyophilized human erythrocytes ⬇️

scientific article published on February 1, 1992

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time ⬇️

scientific article published on January 1, 2013

Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.

scientific article published on 19 January 2011

Protein translation occurs in platelet concentrates despite riboflavin/UV light pathogen inactivation treatment.

scientific article

Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.

scientific article published on 23 November 2011

Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage

scientific article published on 31 March 2017

Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood. ⬇️

scientific article published on 18 November 2016

Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets

scientific article published on 29 March 2016

Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light.

scientific article published on 25 August 2014

Reduction of prion infectivity in packed red blood cells.

scientific article published on 11 October 2008

Refrigerated storage of lyophilized and rehydrated, lyophilized human red cells.

scientific article published in April 1993

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

scientific article

Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.

scientific article published on 13 July 2012

Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment

scientific article published on 22 March 2013

Riboflavin and ultraviolet light: impact on dengue virus infectivity.

scientific article published on 9 June 2016

Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells

scientific article

Selective inactivation of viruses in the presence of human platelets: UV sensitization with psoralen derivatives.

scientific article

Survival of lyophilized and reconstituted human red blood cells in vivo

scientific article published on 01 January 1995

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

scientific article

The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.

scientific article published on July 2010

The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.

scientific article published on 15 April 2011

The effect of riboflavin and ultraviolet light on the infectivity of arboviruses

scientific article

The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection

scientific article

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

scientific article

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination.

scientific article

Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage

scientific article published in August 2015

Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro.

scientific article

Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?

scientific article published on 21 May 2012

Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.

scientific article published on 4 August 2009

Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.

scientific article published on 29 October 2014

List of works by Raymond P Goodrich

<scp>SARS‐CoV</scp>‐2 seroprevalence among blood donors in Uganda: 2019–2022

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

A novel cancer immunotherapy utilizing autologous tumour tissue

A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia

An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage

Characterization of posttransfusion Plasmodium falciparum infection in semi-immune nonparasitemic patients

Chemical and biological mechanisms of pathogen reduction technologies

Comparison of computerized formulae for determination of platelet recovery and survival

Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects

Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light.

Development of a riboflavin and ultraviolet light‐based device to treat whole blood ⬇️

Dramatic improvements in viral inactivation with brominated psoralens, naphthalenes and anthracenes

Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates.

Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies

Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood ⬇️

Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis.

Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.

FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety ⬇️

Functional inactivation of white blood cells by Mirasol treatment.

Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions.

Hemostatic efficacy of pathogen-inactivated- versus untreated- platelets: a randomized controlled trial.

Ignorance is not bliss.

Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice

Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function

Improving blood safety and patient outcomes with pathogen reduction technology

Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.

In reply to: "Is the SCID mouse model applicable to human acute lung injury?".

In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology

In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days

In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood.

Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light

Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates

Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.

Measurement of transmitted light as an indicator of cryopreserved platelet viability

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

Pathogen Reduction of SARS-CoV-2 Virus in Plasma and Whole Blood using Riboflavin and UV Light

Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.

Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.

Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

Pathogen reduction of whole blood: utility and feasibility.

Photochemical and photophysical studies of 3-amino-6-iodoacridine and the inactivation of lambda phage

Photochemical eradication of methicillin-resistant Staphylococcus aureus by blue light activation of riboflavin.

Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system

Pilot Acute Safety Evaluation of Innocell™ Cancer Immunotherapy in Canine Subjects

Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.

Preparation of cryoprecipitate from riboflavin and UV light-treated plasma ⬇️

Preservation of metabolic activity in lyophilized human erythrocytes ⬇️

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time ⬇️

Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.

Protein translation occurs in platelet concentrates despite riboflavin/UV light pathogen inactivation treatment.

Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.

Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage

Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood. ⬇️

Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets

Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light.

Reduction of prion infectivity in packed red blood cells.

Refrigerated storage of lyophilized and rehydrated, lyophilized human red cells.

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.

Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment

Riboflavin and ultraviolet light: impact on dengue virus infectivity.

Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells

Selective inactivation of viruses in the presence of human platelets: UV sensitization with psoralen derivatives.

Survival of lyophilized and reconstituted human red blood cells in vivo

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.

The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.

The effect of riboflavin and ultraviolet light on the infectivity of arboviruses

The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination.

Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage

Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro.

Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?